Postoperative radiotherapy in DBCG during 30 years. Techniques, indications and clinical radiobiological experience

References

• Kaae S, Johansen H. Breast cancer; five year results: Two random series of simple mastectomy with postoperative irradiation versus extended radical mastectomy. Am J Roentgenol Radium Ther Nucl Med 1962; 87: 82–8
   PubMedGoogle Scholar
• Cuzick J, Stewart H, Peto R, Fisher B, Kaae S, Johansen H, et al. Overview of randomized trials comparing radical mastectomy without radiotherapy against simple mastectomy with radiotherapy in breast cancer. Cancer Treat Rep 1987; 71: 7–14
   PubMedGoogle Scholar
• Overgaard, K. [Result of breast cancer treatment at a central hospital.]. Ugeskr Læger. 1961;123:877–9. ( in Danish)
   PubMedGoogle Scholar
• Johansen H, Kaae S, Jensen M-B, Mouridsen HT. Extended radical mastectomy versus simple mastectomy followed by radiotherapy in primary breast cancer. A fifty-year follow-up to the Copenhagen Breast Cancer randomised study. Acta Oncol 2008; 47: 633–38
   PubMed Web of Science ®Google Scholar
• International Commission on Radiation Units and Measurements. ICRU Report 29: Dose specification for reporting external beam therapy with photons and electrons. Bethesda, MD: International Commission on Radiation Units and Measurements; 1978.
   Google Scholar
• Bonadonna G, Valagussa P, Moliterni A, Zambetti M, Brambilla C. Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: The results of 20 years of follow-up. N Engl J Med 1995; 332: 901–6
   PubMed Web of Science ®Google Scholar
• Fisher B, Jeong JH, Anderson S, Wolmark N. Treatment of axillary lymph node-negative, estrogen receptor-negative breast cancer: Updated findings from National Surgical Adjuvant Breast and Bowel Project clinical trials. J Natl Cancer Inst 2004; 96: 1823–31
   PubMedGoogle Scholar
• Blichert-Toft M, Christiansen P, Mouridsen HT. Danish Breast Cancer Cooperative Group – DBCG: History, organisation, and status of scientific achievements at 30-year anniversary. Acta Oncol 2008; 47: 491–96
   PubMedGoogle Scholar
• Møller S, Jensen M-B, Ejlertsen B, Bjerre KG, Larsen M, Hansen HB, et al. The clinical database and the treatment guidelines programmes of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise. Acta Oncol 2008; 47: 506–24
   PubMed Web of Science ®Google Scholar
• Dombernowsky P, Brincker H, Hansen M, Mouridsen HT, Overgaard M, Panduro J, et al. Adjuvant therapy of premenopausal and menopausal high-risk breast cancer patients. Present status of the Danish Breast Cancer Cooperative Group Trials 77-B and 82-B. Acta Oncol 1988; 27: 691–7
   PubMed Web of Science ®Google Scholar
• Mouridsen HT, Rose C, Overgaard M, Dombernowsky P, Panduro J, Thorpe S, et al. Adjuvant treatment of postmenopausal patients with high risk primary breast cancer. Results from the Danish adjuvant trials DBCG 77 C and DBCG 82 C. Acta Oncol 1988; 27: 699–705
   PubMed Web of Science ®Google Scholar
• Overgaard M, Christensen JJ, Johansen H, Nybo-Rasmussen A, Brincker H, van der Kooy P, et al. Postmastectomy irradiation in high-risk breast cancer patients. Present status of the Danish Breast Cancer Cooperative Group trials. Acta Oncol 1988; 27: 707–14
   PubMed Web of Science ®Google Scholar
• von der Maase, H, Sveinsson, T. [Combined irradiation and chemotherapy as postoperative treatment of breast cancer]. Ugeskr Laeger 1978;140:1676–8. (in Danish)
   PubMedGoogle Scholar
• McWhirter R. The value of simple mastectomy and radiotherapy in the treatment of cancer of the breast. Brit J Radiol 1948; 21: 599–610
   PubMed Web of Science ®Google Scholar
• Ellis F. Dose, time and fractionation: A clinical hypothesis. Clin Radiol 1969; 20: 1–7
   PubMedGoogle Scholar
• Kirk J, Gray WM, Watson ER. Cumulative radiation effect. I. Fractionated treatment regimes. Clin Radiol 1971; 22: 145–55
   PubMedGoogle Scholar
• Overgaard M. The clinical implications of non-standard fractionation. Int J Radiat Oncol Biol Phys 1985; 11: 1225–7
   PubMed Web of Science ®Google Scholar
• Overgaard M, Bentzen SM, Christensen JJ, Madsen EH. The value of the NSD formula in equation of acute and late radiation complications in normal tissue following 2 and 5 fractions per week in breast cancer patients treated with postmastectomy irradiation. Radiother Oncol 1987; 9: 1–11
   PubMed Web of Science ®Google Scholar
• Overgaard M. Spontaneous radiation-induced rib fractures in breast cancer patients treated with postmastectomy irradiation. A clinical radiobiological analysis of the influence of fraction size and dose-response relationships on late bone damage. Acta Oncol 1988; 27: 117–22
   PubMed Web of Science ®Google Scholar
• Bentzen SM, Thames HD, Overgaard M. Latent-time estimation for late cutaneous and subcutaneous radiation reactions in a single-follow-up clinical study. Radiother Oncol 1989; 15: 267–74
   PubMed Web of Science ®Google Scholar
• Bentzen SM, Overgaard M, Thames HD. Fractionation sensitivity of a functional endpoint: Impaired shoulder movement after post-mastectomy radiotherapy. Int J Radiat Oncol Biol Phys 1989; 17: 531–7
   PubMed Web of Science ®Google Scholar
• Bentzen SM, Skoczylas JZ, Overgaard M, Overgaard J, Nielsen OG, Madsen EH. Quantitative assessment of radiation-induced lung changes by computerized optical densitometry of routine chest x-rays. Int J Radiat Oncol Biol Phys 1996; 34: 421–7
   PubMed Web of Science ®Google Scholar
• Bentzen SM, Christensen JJ, Overgaard J, Overgaard M. Some methodological problems in estimating radiobiological parameters from clinical data. Alpha/beta ratios and electron RBE for cutaneous reactions in patients treated with postmastectomy radiotherapy. Acta Oncol 1988; 27: 105–16
   PubMed Web of Science ®Google Scholar
• Thames HD, Bentzen SM, Turesson I, Overgaard M, van den Bogaert W. Fractionation parameters for human tissues and tumors. Int J Radiat Biol 1989; 56: 701–10
   PubMed Web of Science ®Google Scholar
• Bentzen SM, Overgaard M, Thames HD, Christensen JJ, Overgaard J. Early and late normal-tissue injury after postmastectomy radiotherapy alone or combined with chemotherapy. Int J Radiat Biol 1989; 56: 711–5
   PubMed Web of Science ®Google Scholar
• Thames HD, Bentzen SM, Turesson I, Overgaard M, Van den Bogaert W. Time-dose factors in radiotherapy: A review of the human data. Radiother Oncol 1990; 19: 219–35
   PubMed Web of Science ®Google Scholar
• Bentzen SM, Overgaard M. Relationship between early and late normal-tissue injury after postmastectomy radiotherapy. Radiother Oncol 1991; 20: 159–65
   PubMed Web of Science ®Google Scholar
• Bentzen SM, Overgaard M. Early and late normal tissue injury after postmastectomy radiotherapy. Recent Results Cancer Res 1993; 130: 59–78
   PubMedGoogle Scholar
• Bentzen SM, Overgaard M, Overgaard J. Clinical correlations between late normal tissue endpoints after radiotherapy: Implications for predictive assays of radiosensitivity. Eur J Cancer 1993; 29A: 1373–6
   PubMed Web of Science ®Google Scholar
• Bentzen SM, Skoczylas JZ, Overgaard M, Overgaard J. Radiotherapy-related lung fibrosis enhanced by tamoxifen. J Natl Cancer Inst 1996; 88: 918–22
   PubMedGoogle Scholar
• Johansen J, Bentzen SM, Overgaard J, Overgaard M. Evidence for a positive correlation between in vitro radiosensitivity of normal human skin ibroblasts and the occurrence of subcutaneous fibrosis after radiotherapy. Int J Radiat Biol 1994; 66: 407–12
   PubMed Web of Science ®Google Scholar
• Johansen J, Taagehøj F, Christensen T, Overgaard J, Overgaard M. Quantitative magnetic resonance for assessment of radiation fibrosis after post-mastectomy radiotherapy. Br J Radiol 1994; 67: 1238–42
   PubMedGoogle Scholar
• Johansen J, Bentzen SM, Overgaard J, Overgaard M. Relationship between the in vitro radiosensitivity of skin fibroblasts and the expression of subcutaneous fibrosis, telangiectasia, and skin erythema after radiotherapy. Radiother Oncol 1996; 40: 101–9
   PubMed Web of Science ®Google Scholar
• Johansen J, Streffer C, Fuhrmann C, Bentzen SM, Stausbøl-Grøn B, Overgaard M, et al. Radiosensitivity of normal fibroblasts from breast cancer patients assessed by the micronucleus and colony assays. Int J Radiat Biol 1998; 73: 671–8
   PubMed Web of Science ®Google Scholar
• Herskind C, Bentzen SM, Overgaard J, Overgaard M, Bamberg M, Rodemann HP. Differentiation state of skin fibroblast cultures versus risk of subcutaneous fibrosis after radiotherapy. Radiother Oncol 1998; 47: 263–9
   PubMed Web of Science ®Google Scholar
• Herskind C, Johansen J, Bentzen SM, Overgaard M, Overgaard J, Bamberg M, et al. Fibroblast differentiation in subcutaneous fibrosis after postmastectomy radiotherapy. Acta Oncol 2000; 39: 383–8
   PubMed Web of Science ®Google Scholar
• Andreassen CN. Can risk of radiotherapy-induced normal tissue complications be predicted from genetic profiles?. Acta Oncol 2005; 44: 801–15
   PubMed Web of Science ®Google Scholar
• Andreassen CN, Alsner J, Overgaard M, Sørensen FB, Overgaard J. Risk of radiation-induced subcutaneous fibrosis in relation to single nucleotide polymorphisms in TGFB1, SOD2, XRCC1, XRCC3, APEX and ATM-a study based on DNA from formalin fixed paraffin embedded tissue samples. Int J Radiat Biol 2006; 82: 577–86
   PubMed Web of Science ®Google Scholar
• Andreassen CN, Overgaard J, Alsner J, Overgaard M, Herskind C, Cesaretti JA, et al. ATM sequence variants and risk of radiation-induced subcutaneous fibrosis after postmastectomy radiotherapy. Int J Radiat Oncol Biol Phys 2006; 64: 776–83
   PubMed Web of Science ®Google Scholar
• Alsner J, Rødningen OK, Overgaard J. Differential gene expression before and after ionizing radiation of subcutaneous fibroblasts identifies breast cancer patients resistant to radiation-induced fibrosis. Radiother Oncol 2007; 83: 261–6
   PubMed Web of Science ®Google Scholar
• Rødningen OK, Børresen-Dale AL, Alsner J, Hastie T, Overgaard J. Radiation-induced gene expression in human subcutaneous fibroblasts is predictive of radiation-induced fibrosis. Radiother Oncol 2008; 86: 314–20
   PubMed Web of Science ®Google Scholar
• Alsner J, Andreassen CN, Overgaard J. Genetic markers for prediction of normal tissue toxicity after radiotherapy. Semin Radiat Oncol 2008; 18: 126–35
   PubMed Web of Science ®Google Scholar
• Fisher B. Laboratory and clinical research in breast cancer–a personal adventure: The David A. Karnofsky memorial lecture. Cancer Res 1980; 40: 3863–74
   PubMed Web of Science ®Google Scholar
• Halsted WS. The results of radical operations for the cure of carcinoma of the breast. Ann Surg 1907; 46: 1
   PubMedGoogle Scholar
• Nielsen HM, Overgaard J, Grau C, Christensen JJ, Overgaard M. Audit of the radiotherapy in the DBCG 82 b&c trials-a validation study of the 1,538 patients randomised to postmastectomy radiotherapy. Radiother Oncol 2005; 76: 285–92
   PubMedGoogle Scholar
• Højris I, Andersen J, Overgaard M, Overgaard J. Late treatment-related morbidity in breast cancer patients randomized to postmastectomy radiotherapy and systemic treatment versus systemic treatment alone. Acta Oncol 2000; 39: 355–72
   PubMed Web of Science ®Google Scholar
• Nielsen HM, Overgaard M, Grau C, Jensen AR, Overgaard J. Loco-regional recurrence after mastectomy in high-risk breast cancer – risk and prognosis. An analysis of patients from the DBCG 82 b&c randomization trials. Radiother Oncol 2006; 79: 147–55
   PubMed Web of Science ®Google Scholar
• Overgaard M, Christensen JJ, Johansen H, Nybo-Rasmussen A, Rose C, van der Kooy P, et al. Evaluation of radiotherapy in high-risk breast cancer patients: Report from the Danish Breast Cancer Cooperative Group (DBCG 82) Trial. Int J Radiat Oncol Biol Phys 1990; 19: 1121–4
   PubMed Web of Science ®Google Scholar
• Nielsen HM, Overgaard M, Grau C, Jensen AR, Overgaard J. Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: Long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies. J Clin Oncol 2006; 24: 2268–75
   PubMed Web of Science ®Google Scholar
• Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 1997; 337: 949–55
   PubMed Web of Science ®Google Scholar
• Overgaard M, Jensen MB, Overgaard J, Hansen PS, Rose C, Andersson M, et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 1999; 353: 1641–8
   PubMed Web of Science ®Google Scholar
• Overgaard M, Nielsen HM, Overgaard J. Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials. Radiother Oncol 2007; 82: 247–53
   PubMed Web of Science ®Google Scholar
• Overgaard M. Overview of randomized trials in high risk breast cancer patients treated with adjuvant systemic therapy with or without postmastectomy irradiation. Semin Radiat Oncol 1999; 9: 292–9
   PubMedGoogle Scholar
• Kyndi M, Sørensen FB, Knudsen H, Overgaard M, Nielsen HM, Overgaard J. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: The Danish Breast Cancer Cooperative Group. J Clin Oncol 2008; 26: 1419–26
   PubMed Web of Science ®Google Scholar
• Kyndi M, Sørensen FB, Knudsen H, Overgaard M, Nielsen HM, Andersen J, et al. Tissue micro arrays compared with whole sections and biochemical analyses. A subgroup analysis of DBCG 82 b&c. Acta Oncol 2008; 47: 591–99
   PubMed Web of Science ®Google Scholar
• Kyndi M, Sørensen FB, Knudsen H, Alsner J, Overgaard M, Nielsen HM, et al. Impact of BCL2 and p53 on post-mastectomy radiotherapy response in high-risk breast cancer. A subgroup analysis of DBCG82 b&c. Acta Oncol 2008; 47: 608–17
   PubMed Web of Science ®Google Scholar
• Kyndi, M, Sørensen, FB, Knudsen, H, Alsner, J, Overgaard, M, Nielsen, HM, et al. Prognostic and predictive value of CA IX in high-risk breast cancer. A subgroup analysis of DBCG82 b&c. Breast Cancer Res 2008; 10:R24.
   PubMed Web of Science ®Google Scholar
• Højris I, Overgaard M, Christensen JJ, Overgaard J. Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: Analysis of DBCG 82b and 82c randomised trials. Lancet 1999; 354: 1425–30
   PubMed Web of Science ®Google Scholar
• Højris I, Sand NP, Andersen J, Rehling M, Overgaard M. Myocardial perfusion imaging in breast cancer patients treated with or without post-mastectomy radiotherapy. Radiother Oncol 2000; 55: 163–72
   PubMedGoogle Scholar
• Timothy AR, Overgaard J, Overgaard M, Wang CC. Treatment of early carcinoma of the breast. Lancet 1979; 2: 25–6
   PubMedGoogle Scholar
• Overgaard, M, Overgaard, J. [Local treatment of cancer of the breast]. Ugeskr Læger 1981;143:1401–4. (in Danish)
   PubMedGoogle Scholar
• Blichert-Toft M, Brincker H, Andersen JA, Andersen KW, Axelsson CK, Mouridsen HT, et al. A Danish randomized trial comparing breast-preserving therapy with mastectomy in mammary carcinoma. Preliminary results. Acta Oncol 1988; 27: 671–7
   PubMed Web of Science ®Google Scholar
• Blichert-Toft, M, Rose, C, Andersen, JA, Overgaard, M, Axelsson, CK, Andersen, KW, et al. Danish randomized trial comparing breast conservation therapy with mastectomy: Six years of life-table analysis. Danish Breast Cancer Cooperative Group. J Natl Cancer Inst Monogr 1992;19–25.
   PubMedGoogle Scholar
• Voogd AC, Nielsen M, Peterse JL, Blichert-Toft M, Bartelink H, Overgaard M, et al. Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: Pooled results of two large European randomized trials. J Clin Oncol 2001; 19: 1688–97
   PubMed Web of Science ®Google Scholar
• Blichert-Toft M, Nielsen M, Düring M, Møller S, Rank F, Overgaard M, et al. Long-term results of breast conserving surgery vs. mastectomy for early stage invasive breast cancer: 20-year follow-up of the Danish randomized DBCG-82TM protocol. Acta Oncol 2008; 47: 672–81
   PubMed Web of Science ®Google Scholar
• Johansen J, Overgaard J, Rose C, Engelholm SA, Gadeberg CC, Kjaer M, et al. Cosmetic outcome and breast morbidity in breast-conserving treatment – results from the Danish DBCG-82TM national randomized trial in breast cancer. Acta Oncol 2002; 41: 369–80
   PubMed Web of Science ®Google Scholar
• Johansen J, Overgaard J, Blichert-Toft M, Overgaard M. Treatment of morbidity associated with the management of the axilla in breast-conserving therapy. Acta Oncol 2000; 39: 349–54
   PubMed Web of Science ®Google Scholar
• Johansen J, Overgaard J, Overgaard M. Effect of adjuvant systemic treatment on cosmetic outcome and late normal-tissue reactions after breast conservation. Acta Oncol 2007; 46: 525–33
   PubMed Web of Science ®Google Scholar
• Cuzick J, Stewart H, Peto R, Fisher B, Kaae S, Johansen H, et al. Overview of randomized trials comparing radical mastectomy without radiotherapy against simple mastectomy with radiotherapy in breast cancer. Cancer Treat Rep 1987; 71: 7–14
   PubMedGoogle Scholar
• Ewertz M, Kempel MM, Düring M, Jensen M-J, Andersson M, Christiansen P, et al. Breast conserving treatment in Denmark, 1989–1998. A nationwide population-based study of the Danish Breast Cancer Co-operative Group. Acta Oncol 2008; 47: 682–90
   PubMed Web of Science ®Google Scholar
• Overgaard M. Radiotherapy as part of a multidisciplinary treatment strategy in early breast cancer. Eur J Cancer 2001; 37(Suppl 7)S33–S43
   PubMedGoogle Scholar
• Nielsen, HM, Overgaard, M. [Survey of a Cochrane review concerning sequencing of adjuvant chemotherapy and postoperative radiotherapy in breast cancer]. Ugeskr Laeger 2007;169:3101–4.( in Danish).
   PubMedGoogle Scholar
• Chen, Z, King, W, Pearcey, R, Kerba, M, Mackillop, WJ. The relationship between waiting time for radiotherapy and clinical outcomes: A systematic review of the literature. Radiother Oncol 2008; 87:3–16.
   PubMed Web of Science ®Google Scholar
• Nielsen HM, Christensen JJ, Aagaard T, Thingholm J, Overgaard M, Grau C. A simple method to test if the internal mammary lymph nodes are covered by the wide tangent technique in radiotherapy for high-risk breast cancer. Clin Oncol 2003; 15: 17–24
   PubMed Web of Science ®Google Scholar
• Shapiro CL, Hardenbergh PH, Gelman R, Blanks D, Hauptman P, Recht A, et al. Cardiac effects of adjuvant doxorubicin and radiation therapy in breast cancer patients. J Clin Oncol 1998; 16: 3493–501
   PubMed Web of Science ®Google Scholar
• Pedersen AN, Korreman S, Nyström H, Specht L. Breathing adapted radiotherapy of breast cancer: Reduction of cardiac and pulmonary doses using voluntary inspiration breath-hold. Radiother Oncol 2004; 72: 53–60
   PubMed Web of Science ®Google Scholar
• Taylor CW, Nisbet A, McGale P, Darby SC. Cardiac exposures in breast cancer radiotherapy: -1990s. Int J Radiat Oncol Biol Phys ;69 1950s; 2007: 1484–95
   Google Scholar
• Thomsen MS, Berg M, Nielsen HM, Pedersen AN, Overgaard M. Ewertz M, et al. @ Post-mastectomy radiotherapy in Denmark: From 2D to 3D treatment planning guidelines of he Danish Breast Cancer Cooperative Group. Acta Oncol 2008; 47: 654–61
   PubMed Web of Science ®Google Scholar
• The START Trialists’ Group. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: A randomised trial. Lancet Oncol 2008; 9:331–41.
   Google Scholar
• The START Trialists’ Group. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: A randomised trial. Lancet 2008; 371:1098–107.
   Google Scholar
• Offersen, BV, Overgaard, M, Kroman, K, Overgaard, J. Accelerated partial breast irradiation as part of breast conserving therapy of early breast carcinoma: A systematic review. (submitted).
   Google Scholar
• Hellman S. Karnofsky Memorial Lecture. Natural history of small breast cancers. J Clin Oncol 1994; 12: 2229–34
   PubMed Web of Science ®Google Scholar
• Bentzen, SM. Quantitative clinical radiobiology. DMSc thesis, Faculty of Health, University of Aarhus. 1994.
   Google Scholar
• Johansen, J. Relationship between in vitro radiosensitivity of normal human skin fibroblasts and the occurrence of late normal tissue reactions after radiotherapy. Ph.D. thesis, Faculty of Health, University of Aarhus. 1995.
   Google Scholar
• Jerzy Skoczylas. Clinical studies of the early and late radiation effect in lung tissue. Ph.D. thesis, Faculty of Health, University of Aarhus. 1995.
   Google Scholar
• Højris, I. Late morbidity following systemic trfeatment with or without postmastectomy irradiation in patients with breast cancer. Ph.D. thesis, Faculty of Health, University of Aarhus. 1999.
   Google Scholar
• Andreassen, CN. Can risk of radiotherapy-induced normal tissue complications be predicted from genetic profiles?, Ph.D. thesis, Faculty of Health, University of Aarhus. 2006.
   Google Scholar
• Nielsen, HM. Failure pattern following adjuvant systemic therapy with or without postmastectomy radiotherapy in high-risk breast cancer patients. Ph.D. thesis, Faculty of Health, University of Aarhus. 2006.
   Google Scholar
• Kyndi, M. Biological markers predictive of response to adjuvant radiotherapy in breast cancer. Ph.D. thesis, Faculty of Health, University of Aarhus. 2008.
   Google Scholar